Skip to content

Reliability and Validity of a New Postoperative Track Assessment Tool

Reliability and Validity of a New Postoperative Track Assessment Tool - a Prospective Observational Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05092867
Acronym
POTraTool
Enrollment
879
Registered
2021-10-26
Start date
2019-08-12
Completion date
2020-10-30
Last updated
2021-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative Complication

Keywords

Post-Anesthesia Care Unit, Intermediate Care Unit, Clinical pathways, Decision making

Brief summary

This prospective observational study investigated the validity and reliability of a new postoperative track assessment tool. We hypothesized, first, that this tool estimates the indication and benefit of a management in an intermediate care unit (IMC). Second, we hypothesized that a) health care providers of IMC or postoperative anaesthesia care unit (PACU) have similar estimations using this tool and b) that this estimation is accurately established in the first 2 hours.

Detailed description

The tool includes 2 visual analog scale (VAS) scores estimating indication of an IMC admission and benefit of an IMC stay. The tool was tested in a PACU and in an IMC unit of a Swiss tertiary centre in 2019/2020 (before COVID pandemic). Three raters: one nurse, one physician in charge and the consultant physician, were asked to fill the VAS at the same time for each included patient. The score was done in the 2 first hours following admission in the unit and during the multi professional morning round at day 1. Reliability was estimated by testing internal consistency (homogeneity), interrater reliability and agreement and test-retest validity (stability). Validity included content validity, construct validity and criterion validity.

Interventions

OTHERPo Tra tool

Healthcare workers filled the 2 VAS of the tool but it did not impact or change the care of the patient. (observational)

Sponsors

University Hospital, Geneva
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* PACU patients admitted on Mondays * IMC patients admitted 7:30am-7:30pm on weekdays

Exclusion criteria

* night admission * PACU patient ASA \< 3 or minor intervention

Design outcomes

Primary

MeasureTime frameDescription
Intermediate Care (IMC) indication (VASi)2019/2020Health care raters graded the IMC indication (or allocative efficiency) for each patient on a visual analog scale grading from 0 (very low indication of an IMC management) to 100 (very high indication of an IMC management), namely VASi.
Intermediate Care benefit (VASb)2019/2020Health care raters graded the IMC benefit (or health gain) for each patient on a visual analog scale grading from 0 (very low benefit from an IMC management) to 100 (very high benefit from an IMC management), namely VASb.

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026